Nasulin intranasal insulin: Preliminary Phase II data

Preliminary data from an open-label, Indian Phase II trial in 80 Type II diabetes patients receiving oral diabetes drugs showed that Nasulin missed the primary endpoints of a 20 mg/dL reduction in pos...